| Date: 2025/10/01 | File Size: 96.94 MB |
| Duration: 00:00:52 | Frame Size: 1920 x 1080 |
Shares of AstraZeneca plc rose 9% on the London Stock Exchange on Wednesday following a U.S.-Pfizer agreement that helped reduce uncertainty in the pharmaceutical sector. The Trump administration indicated it would seek drug-pricing agreements before implementing any tariffs.